Scott Morenstein - Managing Director @ Blackstone

Overview

Number of Current Board & Advisor Roles

CB Rank (Investor)

Scott Morenstein is the Managing Director at Blackstone. Scott Morenstein attended Harvard Business School.

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	AvengeBio	CAM Capital	Yes	Series A - AvengeBio	obfuscated obfuscation
obfuscated obfuscation	Antios Therapeutics	CAM Capital	—	Series B - Antios Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Antios Therapeutics	CAM Capital	—	Series B - Antios Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Primmune Therapeutics	CAM Capital	Yes	Series A - Primmune Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Palvella Therapeutics	CAM Capital	—	Series C - Palvella Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Primmune Therapeutics	CAM Capital	No	Seed Round - Primmune Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Antios Therapeutics	CAM Capital	—	Series A - Antios Therapeutics	obfuscated obfuscation

Number of Current Jobs

has

current jobs as

Managing Director

and

Managing Director

Number of Current Board & Advisor Roles

holds

board and advisor roles including

Board Member

Board Member

, and

Board of Directors

Hub Name	CB Rank (Hub)
Point of Sale Companies With More Than $1M in Revenue	7,363
Point of Sale Companies With More Than $10M in Revenue	38,106
Point of Sale Companies	5,143
Point of Sale Companies With Fewer Than 1000 Employees	7,854
Point of Sale Companies With More Than 10 Employees	10,051

There is no recent news or activity for this profile.